176 related articles for article (PubMed ID: 1820764)
1. Recurrence rates of treated basal cell carcinomas. Part 2: Curettage-electrodesiccation.
Silverman MK; Kopf AW; Grin CM; Bart RS; Levenstein MJ
J Dermatol Surg Oncol; 1991 Sep; 17(9):720-6. PubMed ID: 1820764
[TBL] [Abstract][Full Text] [Related]
2. Recurrence rates of treated basal cell carcinomas. Part 3: Surgical excision.
Silverman MK; Kopf AW; Bart RS; Grin CM; Levenstein MS
J Dermatol Surg Oncol; 1992 Jun; 18(6):471-6. PubMed ID: 1592998
[TBL] [Abstract][Full Text] [Related]
3. Recurrence rates of treated basal cell carcinomas. Part 1: Overview.
Silverman MK; Kopf AW; Grin CM; Bart RS; Levenstein MJ
J Dermatol Surg Oncol; 1991 Sep; 17(9):713-8. PubMed ID: 1890243
[TBL] [Abstract][Full Text] [Related]
4. Recurrence rates of primary basal cell carcinoma in facial risk areas treated with curettage and electrodesiccation.
Rodriguez-Vigil T; Vázquez-López F; Perez-Oliva N
J Am Acad Dermatol; 2007 Jan; 56(1):91-5. PubMed ID: 17190625
[TBL] [Abstract][Full Text] [Related]
5. Recurrence rates of treated basal cell carcinomas. Part 4: X-ray therapy.
Silverman MK; Kopf AW; Gladstein AH; Bart RS; Grin CM; Levenstein MJ
J Dermatol Surg Oncol; 1992 Jul; 18(7):549-54. PubMed ID: 1624628
[TBL] [Abstract][Full Text] [Related]
6. Recurrence rates of aggressive histologic types of basal cell carcinoma after treatment with electrodesiccation and curettage alone.
Blixt E; Nelsen D; Stratman E
Dermatol Surg; 2013 May; 39(5):719-25. PubMed ID: 23379543
[TBL] [Abstract][Full Text] [Related]
7. Multivariate risk score for recurrence of cutaneous basal cell carcinomas.
Dubin N; Kopf AW
Arch Dermatol; 1983 May; 119(5):373-7. PubMed ID: 6847215
[TBL] [Abstract][Full Text] [Related]
8. Failure of curettage and electrodesiccation for removal of basal cell carcinoma.
Suhge d'Aubermont PC; Bennett RG
Arch Dermatol; 1984 Nov; 120(11):1456-60. PubMed ID: 6497413
[TBL] [Abstract][Full Text] [Related]
9. Curettage-electrodesiccation treatment of basal cell carcinomas.
Kopf AW; Bart RS; Schrager D; Lazar M; Popkin GL
Arch Dermatol; 1977 Apr; 113(4):439-43. PubMed ID: 848972
[TBL] [Abstract][Full Text] [Related]
10. Multifocal recurrent basal cell carcinoma following primary tumor treatment by electrodesiccation and curettage.
Wagner RF; Cottel WI
J Am Acad Dermatol; 1987 Dec; 17(6):1047-9. PubMed ID: 3429717
[TBL] [Abstract][Full Text] [Related]
11. Recurrence rates of primary nonmelanoma skin cancers treated by surgical excision compared to electrodesiccation-curettage in a private dermatological practice.
Werlinger KD; Upton G; Moore AY
Dermatol Surg; 2002 Dec; 28(12):1138-42; discussion 1142. PubMed ID: 12472494
[TBL] [Abstract][Full Text] [Related]
12. Treatment of basal cell epithelioma by curettage and electrodesiccation.
Spiller WF; Spiller RF
J Am Acad Dermatol; 1984 Nov; 11(5 Pt 1):808-14. PubMed ID: 6512037
[TBL] [Abstract][Full Text] [Related]
13. Prospective Clinical Trial Comparing Curettage and Cryosurgery to Curettage and Electrodesiccation in the Management of Minimally Invasive Basal and Squamous Cell Carcinomas [Formula: see text].
Fournier S; Laroche A; Leblanc M; Bourgeault E; Ulrich Singbo MN; Turcotte S; Blouin MM; Alain J
J Cutan Med Surg; 2020; 24(6):596-600. PubMed ID: 32721237
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of curettage and electrodesiccation in the removal of basal cell carcinoma.
Edens BL; Bartlow GA; Haghighi P; Astarita RW; Davidson TM
J Am Acad Dermatol; 1983 Sep; 9(3):383-8. PubMed ID: 6630599
[TBL] [Abstract][Full Text] [Related]
15. Whole specimen intraoperative frozen section analysis. Experience with 1082 basal cell carcinomas.
Kedilioglu MA; Bos PG; De Jong K; Noordzij NA; Kibbelaar RE; Lapid O; Mouës CM
Eur J Surg Oncol; 2018 Jan; 44(1):157-162. PubMed ID: 29198817
[TBL] [Abstract][Full Text] [Related]
16. Topical imiquimod therapy for basal and squamous cell carcinomas: a clinical experience.
Tillman DK; Carroll MT
Cutis; 2007 Mar; 79(3):241-8. PubMed ID: 17674590
[TBL] [Abstract][Full Text] [Related]
17. Low recurrence rate of head and neck basal cell carcinoma treated with Mohs micrographic surgery: A retrospective study of 1021 cases.
Kuiper EM; van den Berge BA; Spoo JR; Kuiper J; Terra JB
Clin Otolaryngol; 2018 Oct; 43(5):1321-1327. PubMed ID: 29953746
[TBL] [Abstract][Full Text] [Related]
18. Recurrent basal cell carcinoma: a clinicopathological study and evaluation of histomorphological findings in primary and recurrent lesions.
Bartoš V; Pokorný D; Zacharová O; Haluska P; Doboszová J; Kullová M; Adamicová K; Péč M; Péč J
Acta Dermatovenerol Alp Pannonica Adriat; 2011 Jun; 20(2):67-75. PubMed ID: 21993704
[TBL] [Abstract][Full Text] [Related]
19. Basal cell carcinoma and squamous cell carcinoma growth rates and determinants of size in community patients.
Kricker A; Armstrong B; Hansen V; Watson A; Singh-Khaira G; Lecathelinais C; Goumas C; Girgis A
J Am Acad Dermatol; 2014 Mar; 70(3):456-64. PubMed ID: 24373780
[TBL] [Abstract][Full Text] [Related]
20. Biopsy followed by immediate curettage and electrodesiccation of suspected basal cell carcinomas at the first visit.
White GM; Zhou HC; Burchette RJ
JAMA Dermatol; 2013 Aug; 149(8):980-1. PubMed ID: 23760141
[No Abstract] [Full Text] [Related]
[Next] [New Search]
